GO:0008480 sarcosine dehydrogenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008480 (sarcosine dehydrogenase activity) catalyzes the oxidative demethylation of sarcosine (N-methylglycine) to glycine, formaldehyde, and reduced electron-transfer flavoprotein.
• The enzyme is a mitochondrial matrix flavoprotein that uses electron-transfer flavoprotein (ETF) as its physiological electron acceptor.
• Sarcosine dehydrogenase activity is developmentally regulated in liver mitochondria, with higher activity in infant versus adult rats.
• The enzyme can be studied in immobilized or vesicle-reconstituted systems, enabling biophysical and biosensor applications.
• Sarcosine metabolism intersects with one-carbon/folate pathways, linking GO:0008480 to methylation and mitochondrial translation.
• Dysregulated sarcosine dehydrogenase has been implicated in cancer biology, including gallbladder cancer progression and lung adenocarcinoma chemosensitivity.
Description
Sarcosine dehydrogenase activity (GO:0008480) is a mitochondrial molecular function that removes a methyl group from sarcosine (N-methylglycine) to produce glycine, formaldehyde, and reduced electron-transfer flavoprotein. This reaction sits at the intersection of amino acid catabolism, one-carbon metabolism, and mitochondrial electron transfer, making it relevant to basic enzymology and to disease-oriented research. The enzyme has been characterized biochemically in rat liver mitochondria, where its activity changes with developmental stage. Because sarcosine is a metabolite of interest in oncology and methylation biology, the dehydrogenase that consumes it is a natural focus for functional studies. The reaction is also notable for its use of electron-transfer flavoprotein rather than NAD+ or FAD as the immediate electron acceptor, which distinguishes it from many classical dehydrogenases. Understanding GO:0008480 therefore requires attention to substrate specificity, cofactor handling, mitochondrial localization, and the broader metabolic context in which sarcosine is produced and consumed.
sarcosine dehydrogenase activity At A Glance
| GO ID | GO:0008480 |
|---|---|
| GO term | sarcosine dehydrogenase activity |
| Ontology | molecular_function |
| Synonym | monomethylglycine dehydrogenase activity; sarcosine:(acceptor) oxidoreductase (demethylating); sarcosine:acceptor oxidoreductase (demethylating); sarcosine N-demethylase activity |
| Major function | Oxidative demethylation of sarcosine to glycine, formaldehyde, and reduced electron-transfer flavoprotein |
| Reaction | sarcosine + H2O + electron-transfer flavoprotein = glycine + formaldehyde + reduced electron-transfer flavoprotein |
| Electron acceptor | Electron-transfer flavoprotein (ETF) |
| Subcellular context | Mitochondrial matrix (as characterized in liver mitochondria) |
| Developmental note | Activity differs between infant and adult rat liver mitochondria |
What Is GO:0008480?
In simple terms, GO:0008480 describes an enzyme activity that breaks down sarcosine by removing a methyl group. The official definition states: Catalysis of the reaction: sarcosine + H2O + electron-transfer flavoprotein = glycine + formaldehyde + reduced electron-transfer flavoprotein. This is an oxidative demethylation reaction in which the methyl group of sarcosine is converted to formaldehyde, while the electrons are transferred to electron-transfer flavoprotein. The activity is also known as monomethylglycine dehydrogenase activity, sarcosine:(acceptor) oxidoreductase (demethylating), sarcosine:acceptor oxidoreductase (demethylating), and sarcosine N-demethylase activity. It is a molecular_function term in the Gene Ontology and is typically associated with the mitochondrial matrix in eukaryotic cells.
Why Is sarcosine dehydrogenase activity Important in Cell Biology?
GO:0008480 is important because it defines the only known enzymatic route for the direct oxidative demethylation of sarcosine to glycine in mitochondria, connecting amino acid catabolism to one-carbon metabolism and mitochondrial electron transfer. Sarcosine is a metabolite with recognized roles in cancer biology and methylation status, so the enzyme that consumes it is a key node for understanding how sarcosine levels are controlled. The reaction also produces formaldehyde, a reactive one-carbon unit, which links this activity to folate-dependent processes and mitochondrial translation. Because the enzyme uses electron-transfer flavoprotein, it provides a model for studying flavoprotein-mediated electron transfer in a mitochondrial context. Finally, the developmental regulation of the enzyme in liver mitochondria suggests roles in metabolic maturation and adaptation.
• Defines a specific mitochondrial oxidative demethylation reaction that consumes sarcosine and produces glycine.
• Links sarcosine metabolism to one-carbon/folate pathways and mitochondrial translation.
• Provides a biochemical model for electron-transfer flavoprotein-dependent dehydrogenases.
• Shows developmental regulation in liver mitochondria, relevant to metabolic maturation.
• Is relevant to cancer biology because sarcosine levels and sarcosine dehydrogenase expression are altered in some tumors.
• Supports studies of formaldehyde production and one-carbon flux in mitochondria.
• Can be studied in reconstituted or immobilized systems for biosensor and biophysical applications.
• Connects to anaerobic glycine metabolism, where sarcosine dehydrogenase-like activities contribute to glycine catabolism.
• Offers a target for functional genomics and CRISPR-based validation of metabolic enzymes.
• Helps interpret metabolomic and flux data in studies of methylation and redox balance.
Molecular Mechanism of sarcosine dehydrogenase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs sarcosine and holds it in place.
Sarcosine dehydrogenase activity is defined by the ability to bind sarcosine (N-methylglycine) and catalyze its demethylation. The enzyme is a mitochondrial flavoprotein that acts on sarcosine as its primary substrate, distinguishing it from related enzymes such as dimethylglycine dehydrogenase, which acts on dimethylglycine. Substrate specificity studies of the rat liver enzyme have helped define the structural requirements for sarcosine binding and turnover.
Catalytic demethylation and formaldehyde release
In simple terms: The enzyme removes a methyl group from sarcosine and turns it into formaldehyde.
The catalytic step converts sarcosine to glycine and formaldehyde, with the methyl group released as formaldehyde. This oxidative demethylation is the defining chemical transformation of GO:0008480 and is distinct from simple dehydrogenation because it involves removal of a methyl group rather than oxidation of a carbon skeleton. The reaction requires water and proceeds through a flavin-dependent mechanism in which the substrate is oxidized and the methyl group is transferred to water-derived oxygen.
Electron transfer to electron-transfer flavoprotein
In simple terms: The electrons removed from sarcosine are handed off to a carrier protein called ETF.
The physiological electron acceptor for sarcosine dehydrogenase is electron-transfer flavoprotein (ETF), which becomes reduced during the reaction. This distinguishes the enzyme from NAD+-dependent dehydrogenases and places it within the mitochondrial ETF-linked dehydrogenase family. The reduced ETF generated by this reaction can feed electrons into the respiratory chain, linking sarcosine oxidation to mitochondrial energy metabolism.
Mitochondrial localization and developmental regulation
In simple terms: The enzyme works inside mitochondria, and its levels change as animals grow.
Sarcosine dehydrogenase activity has been measured in liver mitochondria, where it is localized to the mitochondrial matrix. Studies comparing infant and adult rats show that the activity is developmentally regulated, with different levels in infant versus adult liver mitochondria. This suggests that the enzyme is part of the metabolic remodeling that occurs during postnatal development.
Biophysical and immobilized enzyme behavior
In simple terms: The enzyme can be attached to artificial surfaces and still work.
Sarcosine dehydrogenase has been immobilized onto giant vesicles, and its enzymatic activity and stability have been characterized in that context. Such reconstitution studies show that the enzyme retains activity when associated with lipid membranes, which is useful for biosensor design and for understanding membrane-enzyme interactions. These approaches complement solution-based kinetic studies of the enzyme.
Key Genes Involved in GO:0008480 sarcosine dehydrogenase activity
The genes and proteins most directly associated with GO:0008480 include the sarcosine dehydrogenase enzyme itself and related mitochondrial flavoproteins and one-carbon metabolic enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SARDH | Encodes sarcosine dehydrogenase, the enzyme carrying GO:0008480 activity | Core gene for functional studies of sarcosine catabolism and cancer metabolism |
| DMGDH | Encodes dimethylglycine dehydrogenase, a related mitochondrial flavoprotein | Comparative enzymology with sarcosine dehydrogenase |
| ETFA | Encodes the alpha subunit of electron-transfer flavoprotein | Provides the electron acceptor for sarcosine dehydrogenase |
| ETFB | Encodes the beta subunit of electron-transfer flavoprotein | Part of the ETF complex that accepts electrons from sarcosine dehydrogenase |
| ETFDH | Encodes electron-transfer flavoprotein dehydrogenase | Links ETF-reducing enzymes to the respiratory chain |
| GLDC | Encodes glycine decarboxylase, which also acts on glycine | Connects glycine metabolism to one-carbon flux |
| AMT | Encodes aminomethyltransferase, part of the glycine cleavage system | Related to glycine and one-carbon metabolism |
| MTHFD1L | Encodes a mitochondrial one-carbon enzyme | Links mitochondrial one-carbon metabolism to folate pathways |
| MTHFD2 | Encodes a mitochondrial one-carbon enzyme | Relevant to folate-dependent mitochondrial translation |
| SHMT2 | Encodes serine hydroxymethyltransferase 2 | Provides glycine and one-carbon units in mitochondria |
| PDK4 | Encodes pyruvate dehydrogenase kinase 4 | Implicated in sarcosine-related ferroptosis signaling |
| PDHA1 | Encodes pyruvate dehydrogenase E1 alpha | Part of the PDK4/PDHA1 axis linked to sarcosine effects |
| GATM | Encodes glycine amidinotransferase | Glycine metabolism context for sarcosine dehydrogenase |
| PIPOX | Encodes pipecolic acid oxidase, a peroxisomal flavoprotein | Related flavoprotein oxidase for comparative studies |
| PRODH | Encodes proline dehydrogenase | Mitochondrial flavoprotein dehydrogenase for comparison |
| DLD | Encodes dihydrolipoamide dehydrogenase | Shared component of mitochondrial dehydrogenase complexes |
| GCSH | Encodes glycine cleavage system H protein | Glycine metabolism and one-carbon links |
How Is sarcosine dehydrogenase activity Regulated?
Sarcosine dehydrogenase activity is developmentally regulated in liver mitochondria, with measurable differences between infant and adult rats. The enzyme is a mitochondrial flavoprotein, and its activity depends on the availability of electron-transfer flavoprotein as an electron acceptor. Folate status can influence mitochondrial one-carbon metabolism and methylation reactions, which may indirectly affect sarcosine-related pathways. In cancer contexts, sarcosine dehydrogenase expression and sarcosine levels are associated with signaling changes, including chemokine pathways in gallbladder cancer and PDK4/PDHA1-related ferroptosis in lung adenocarcinoma. These observations suggest that regulation occurs at the intersection of developmental, metabolic, and disease-specific signals.
sarcosine dehydrogenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SARDH | Gallbladder cancer progression via chemokine pathways | Knockout and overexpression in gallbladder cancer cell lines |
| SARDH | Lung adenocarcinoma chemosensitivity and ferroptosis | Point mutation and knockout in lung adenocarcinoma cells |
| MTHFD1L | Folate-dependent mitochondrial translation | Knockout in mitochondrial translation reporter cells |
| SHMT2 | One-carbon metabolism and methylation | Knock-in of tagged alleles for metabolic flux studies |
| PDK4 | Sarcosine-related ferroptosis signaling | Overexpression and knockout in lung cancer models |
Sarcosine dehydrogenase in gallbladder cancer
Sarcosine dehydrogenase has been studied in the progression of gallbladder cancer, where it appears to act through chemokine pathways. This work links the enzyme to tumor progression and suggests that sarcosine metabolism may influence immune or inflammatory signaling in the tumor microenvironment. The findings support further investigation of GO:0008480-related activity as a potential biomarker or therapeutic target in biliary cancers.
Sarcosine and lung adenocarcinoma chemosensitivity
Sarcosine has been shown to sensitize lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export. This places sarcosine metabolism, and by extension the enzyme that consumes sarcosine, in the context of chemotherapy response and ferroptosis. The study highlights how sarcosine levels can modulate cell death pathways and treatment outcomes.
One-carbon metabolism and mitochondrial translation
Folate-dependent one-carbon metabolism is required for mitochondrial translation, and disruptions in this pathway affect tRNA methylation and mitochondrial function. Sarcosine dehydrogenase produces formaldehyde and glycine, both of which intersect with one-carbon pools. Folate deficiency has also been linked to changes in histone methylation, indicating that one-carbon status can influence epigenetic marks. These connections suggest that GO:0008480 may contribute to broader metabolic and epigenetic regulation.
Glycine metabolism in anaerobic organisms
Glycine metabolism in anaerobes involves enzymes that can carry out sarcosine dehydrogenase-like reactions, underscoring the evolutionary conservation of this activity. These microbial systems provide comparative models for understanding the catalytic mechanism and metabolic role of sarcosine oxidation. Such studies help place GO:0008480 within a broader framework of glycine and one-carbon metabolism across organisms.
From sarcosine dehydrogenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of sarcosine dehydrogenase activity alter sarcosine levels? | SARDH knockout cell lines |
| Does a specific catalytic residue control demethylation? | Point mutation of predicted active-site residues |
| Can sarcosine dehydrogenase be tracked in live cells? | Knock-in of fluorescent or affinity tags |
| Does overexpression change chemosensitivity? | SARDH overexpression in cancer cell lines |
| Which metabolic pathways depend on sarcosine dehydrogenase? | Knockout combined with metabolomics and flux analysis |
| Can the enzyme be reconstituted on membranes? | Immobilized enzyme on giant vesicles |
How to Study the sarcosine dehydrogenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay with ETF or artificial acceptor | Sarcosine-dependent electron transfer | Kinetic characterization of sarcosine dehydrogenase |
| Formaldehyde detection | Production of formaldehyde from sarcosine | Confirmation of demethylation activity |
| Metabolomics | Sarcosine, glycine, and related metabolites | Pathway flux and biomarker studies |
| Stable isotope tracing | Carbon flux into one-carbon pools | Folate-dependent metabolism studies |
| Immobilized enzyme on giant vesicles | Activity and stability in membrane context | Biosensor and biophysical studies |
| CRISPR knockout | Loss-of-function phenotype | Causal testing of SARDH in cancer models |
| Overexpression | Gain-of-function phenotype | Chemosensitivity and ferroptosis studies |
| Developmental activity profiling | Activity changes across ages | Liver mitochondrial maturation studies |
Enzymatic activity assays
Direct measurement of sarcosine dehydrogenase activity uses substrate-dependent electron transfer to electron-transfer flavoprotein or artificial acceptors, as established for the rat liver enzyme. These assays can be adapted to monitor demethylation and formaldehyde release. Immobilized enzyme preparations on giant vesicles provide a complementary format for activity and stability measurements.
Metabolomics and flux analysis
Because sarcosine dehydrogenase consumes sarcosine and produces glycine and formaldehyde, metabolomic profiling of these metabolites is a direct way to assess pathway activity. Stable isotope tracing can reveal how sarcosine-derived carbons enter one-carbon pools. Such approaches are especially useful in cancer models where sarcosine levels affect drug response.
Genetic and CRISPR-based perturbation
Knockout, point mutation, and overexpression of SARDH allow causal testing of GO:0008480 in cells and animal models. These perturbations can be combined with chemokine profiling or ferroptosis assays to link enzyme activity to disease phenotypes. Developmental studies in rats provide a historical framework for comparing activity across ages.
Biochemical reconstitution and biophysics
Reconstitution of sarcosine dehydrogenase on lipid vesicles enables studies of membrane association, stability, and electron transfer. These systems can be used to test how lipid environment affects catalytic efficiency. Comparative studies with related flavoproteins such as dimethylglycine dehydrogenase help define specificity determinants.
How CRISPR Can Be Used to Study GO:0008480 sarcosine dehydrogenase activity
Knockout
CRISPR knockout of SARDH can eliminate sarcosine dehydrogenase activity, allowing researchers to test how loss of GO:0008480 affects sarcosine and glycine levels. Such models are useful for studying cancer progression and chemokine signaling in gallbladder cancer. Knockout also provides a clean background for rescue experiments with wild-type or mutant enzyme.
Point Mutation
Point mutations in SARDH can be introduced to test catalytic residues or regulatory sites predicted from enzyme studies. These models help distinguish loss of catalytic activity from loss of protein expression. They are also valuable for dissecting electron transfer to electron-transfer flavoprotein.
Knock-in
Knock-in of tags or reporters into the SARDH locus enables tracking of enzyme localization and abundance in mitochondria. Tagged knock-in lines can be used for affinity purification and interaction studies. This approach is compatible with live-cell imaging and proteomic workflows.
Overexpression
Overexpression of SARDH allows gain-of-function studies, such as testing whether increased sarcosine dehydrogenase activity alters chemosensitivity or ferroptosis. These models can be combined with metabolomics to measure changes in sarcosine and one-carbon metabolites. Overexpression in cancer cell lines is a practical way to link GO:0008480 to disease phenotypes.
How EDITGENE Supports sarcosine dehydrogenase activity Research
Researchers studying sarcosine dehydrogenase activity-related genes often need to determine whether a candidate gene is causally involved in a metabolic or disease phenotype, and CRISPR-based models provide a direct way to test that causality. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to move from correlation to mechanism in the sarcosine dehydrogenase pathway.
Contact EDITGENE today to design your custom CRISPR model for sarcosine dehydrogenase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SARDH Knockout HEK293 Cell Line | EDJ-KQ2955 | Human | 1757 | Details Get a Quote |
| SARDH Knockout HCT 116 Cell Line | EDJ-KQ24094 | Human | 1757 | Details Get a Quote |
| SARDH Knockout HeLa Cell Line | EDJ-KQ53094 | Human | 1757 | Details Get a Quote |
| SARDH Knockout A-549 Cell Line | EDJ-KQ61567 | Human | 1757 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About sarcosine dehydrogenase activity
What is sarcosine dehydrogenase activity?
Sarcosine dehydrogenase activity (GO:0008480) is the catalysis of the reaction sarcosine + H2O + electron-transfer flavoprotein = glycine + formaldehyde + reduced electron-transfer flavoprotein.
What is the GO ID for sarcosine dehydrogenase activity?
The Gene Ontology ID for sarcosine dehydrogenase activity is GO:0008480.
What reaction does sarcosine dehydrogenase catalyze?
It catalyzes the oxidative demethylation of sarcosine to glycine and formaldehyde, transferring electrons to electron-transfer flavoprotein.
What genes are involved in sarcosine dehydrogenase activity?
The core gene is SARDH, which encodes sarcosine dehydrogenase; related genes include DMGDH, ETFA, ETFB, and ETFDH.
Where is sarcosine dehydrogenase active in the cell?
It is active in the mitochondrial matrix, as characterized in liver mitochondria.
Is sarcosine dehydrogenase activity developmentally regulated?
Yes, studies in rats show different activity levels in infant versus adult liver mitochondria.
How is sarcosine dehydrogenase activity measured?
It can be measured by enzyme assays monitoring electron transfer to electron-transfer flavoprotein or artificial acceptors, and by formaldehyde production.
Can sarcosine dehydrogenase be studied on artificial membranes?
Yes, the enzyme has been immobilized onto giant vesicles and retains activity and stability in that context.
What diseases are linked to sarcosine dehydrogenase?
It has been linked to gallbladder cancer progression through chemokine pathways and to sarcosine-related chemosensitivity in lung adenocarcinoma.
How can CRISPR help study sarcosine dehydrogenase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of SARDH function in metabolic and disease phenotypes.
Conclusion
GO:0008480 defines a specific mitochondrial oxidative demethylation reaction that converts sarcosine to glycine and formaldehyde while reducing electron-transfer flavoprotein. Its study connects fundamental enzymology with developmental regulation, one-carbon metabolism, and cancer biology. CRISPR-based models and biochemical assays provide complementary tools to dissect the mechanism and disease relevance of sarcosine dehydrogenase activity.
References
- 1. Morscher RJ et al.. 2018. Mitochondrial translation requires folate-dependent tRNA methylation.. Nature 554(7690):128-132 PMID: 29364879
- 2. Porter DH et al.. 1985. Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver.. Arch Biochem Biophys 243(2):396-407 PMID: 2417560
- 3. Honová E et al.. 1967. Sarcosine dehydrogenase activity in liver mitochondria of infant and adult rats.. Experientia 23(8):632-3 PMID: 6051684
- 4. Kato K et al.. 2003. Enzymatic activity and stability of D-fructose dehydrogenase and sarcosine dehydrogenase immobilized onto giant vesicles.. Biotechnol Bioeng 84(4):415-23 PMID: 14574698
- 5. Andreesen JR. 1994. Glycine metabolism in anaerobes.. Antonie Van Leeuwenhoek 66(1-3):223-37 PMID: 7747933
- 6. Shan G et al.. 2025. Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export.. Exp Hematol Oncol 14(1):60 PMID: 40275333
- 7. Garcia BA et al.. 2016. Folate deficiency affects histone methylation.. Med Hypotheses 88:63-7 PMID: 26880641
- 8. Gao Z et al.. 2025. Role and mechanism of sarcosine dehydrogenase in the progression of gallbladder cancer through chemokine pathways.. World J Gastrointest Oncol 17(6):105016 PMID: 40547148
